CardioNet, Inc. Files Resale Registration Statement
June 23 2008 - 8:00AM
Business Wire
CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical
technology company with an initial focus on the diagnosis and
monitoring of cardiac arrhythmias, today filed a resale
registration statement with the SEC related to the shares that were
underlying the Mandatorily Redeemable Convertible Preferred Stock
issued in March 2007. The shares being registered remain subject to
lock-up agreements entered into in connection with CardioNet�s IPO,
pursuant to which the holders have agreed not to sell such shares
until at least September 15, 2008. Marty Galvan, CardioNet's Chief
Financial Officer, commented: �We have filed this registration
statement to satisfy a contractual obligation related to our March
2007 financing. CardioNet is not issuing new shares. The shares
that were underlying the Mandatorily Redeemable Convertible
Preferred Stock will remain subject to the IPO lock-up agreements,
even upon the registration statement being declared effective.�
About CardioNet CardioNet, Inc. is a leading provider of
ambulatory, continuous, real-time outpatient management solutions
for monitoring relevant and timely clinical information regarding
an individual�s health. CardioNet�s initial efforts are focused on
the diagnosis and monitoring of cardiac arrhythmias with a solution
that it markets as the CardioNet System. More information can be
found at http://www.CardioNet.com.
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jul 2023 to Jul 2024